Nanomedicine in Translational Research: Status and Future Challenges
Editat de Kaladhar Kamalasanan, Chandra P. Sharmaen Limba Engleză Paperback – 24 sep 2024
- Focuses on the pillars contributing to the global healthcare crisis: geopolitical changes, overpopulation/migration, and climate change.
- Includes personal interviews with many world leaders in different areas along with the authors’ hands-on experience on healthcare, especially during the COVID-19 pandemic, for drafting the contents that confirm advanced healthcare.
- Provides a broad and multidisciplinary understanding of healthcare, allowing the readers to understand their role and empower them to take initiatives to emerging solutions.
Preț: 824.08 lei
Preț vechi: 1080.80 lei
-24% Nou
Puncte Express: 1236
Preț estimativ în valută:
157.76€ • 163.99$ • 130.80£
157.76€ • 163.99$ • 130.80£
Carte tipărită la comandă
Livrare economică 30 ianuarie-13 februarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780443222573
ISBN-10: 0443222576
Pagini: 426
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0443222576
Pagini: 426
Dimensiuni: 191 x 235 mm
Greutate: 0.45 kg
Editura: ELSEVIER SCIENCE
Cuprins
- Introduction
- Properties of biomaterials at nano range
- In vitro systems to demonstrate the nano effect
- Toxicology of biomaterials at nanoscale
- Porphyrinoid-based single molecule to nano theranostics towards personalized diagnosis and treatment
- Nanomaterials for biomedical applications
- Nanosystems - combination products
- Biomass derived carbon nanodots
- Nanosystems for Pharmaceutical applications
- Scope of Biomaterials for theranostics application
- Redox Nanotherapeutics: Fundamentals and Applications
- Smart Therapeutics: Evolution from small biomolecules to synthetic cells
- Applications of Artificial Intelligence and Machine Learning Models in Nanotherapeutics.
- Nanomedicine in Patient-specific Clinical Trend: Shape memory polymers of emerging biomedical applications and their future prospects
- Commercialized nanomedicines until to date
- Nanosystems development, Quality Control requirements and ethical issues
- Affordable and accessible nanomedicines: Regulatory perspectives from right to health